121 related articles for article (PubMed ID: 6184590)
1. Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
Wood PL; Etienne P; Lal S; Gauthier S; Cajal S; Nair NP
Life Sci; 1982 Nov; 31(19):2073-9. PubMed ID: 6184590
[No Abstract] [Full Text] [Related]
2. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
[TBL] [Abstract][Full Text] [Related]
3. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
Losonczy MF; Mohs RC; Davis KL
Psychiatry Res; 1984 May; 12(1):79-87. PubMed ID: 6205414
[TBL] [Abstract][Full Text] [Related]
4. [CSF somatostatin and amine metabolites in spinocerebellar degenerations].
Shimoda K; Hikasa C; Nishikawa S; Takahashi K
Rinsho Shinkeigaku; 1987 Aug; 27(8):996-1001. PubMed ID: 2446812
[No Abstract] [Full Text] [Related]
5. Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.
Degrell I; Nagy E
Biol Psychiatry; 1990 Apr; 27(8):891-6. PubMed ID: 1691925
[TBL] [Abstract][Full Text] [Related]
6. Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
Freed DM; Corkin S; Growdon JH; Nissen MJ
Neuropsychologia; 1988; 26(6):895-902. PubMed ID: 2461537
[TBL] [Abstract][Full Text] [Related]
7. CSF monoamine metabolites in old age dementias.
Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U
Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590
[TBL] [Abstract][Full Text] [Related]
8. Monoamine activity correlates with psychometric deficits in Korsakoff's disease.
Mair RG; McEntee WJ; Zatorre RJ
Behav Brain Res; 1985 May; 15(3):247-54. PubMed ID: 2408635
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease.
Kaye JA; May C; Atack JR; Daly E; Sweeney DL; Beal MF; Kaufman S; Milstien S; Friedland RP; Rapoport SI
Ann Neurol; 1988 Nov; 24(5):647-50. PubMed ID: 2462403
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
Kaye JA; May C; Daly E; Atack JR; Sweeney DJ; Luxenberg JS; Kay AD; Kaufman S; Milstien S; Friedland RP
Neurology; 1988 Apr; 38(4):554-7. PubMed ID: 2451190
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders.
McEntee WJ; Mair RG; Langlais PJ
Neurology; 1984 May; 34(5):648-52. PubMed ID: 6200802
[TBL] [Abstract][Full Text] [Related]
12. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
Mann JJ; Stanley M; Neophytides A; de Leon MJ; Ferris SH; Gershon S
Neurobiol Aging; 1981; 2(1):57-60. PubMed ID: 7266742
[TBL] [Abstract][Full Text] [Related]
13. Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity.
McEntee WJ; Mair RG
Science; 1978 Nov; 202(4370):905-7. PubMed ID: 715450
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system catecholamine metabolism in Korsakoff's psychosis.
Martin PR; Weingartner H; Gordon EK; Burns RS; Linnoila M; Kopin IJ; Ebert MH
Ann Neurol; 1984 Feb; 15(2):184-7. PubMed ID: 6200058
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid biopterin is decreased in Alzheimer's disease.
Kay AD; Milstien S; Kaufman S; Creasey H; Haxby JV; Cutler NR; Rapoport SI
Arch Neurol; 1986 Oct; 43(10):996-9. PubMed ID: 2428341
[TBL] [Abstract][Full Text] [Related]
16. Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL).
Argentiero V; Tavolato B
J Neurol; 1980; 224(1):53-8. PubMed ID: 6157799
[TBL] [Abstract][Full Text] [Related]
17. Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications?
Bareggi SR; Franceschi M; Bonini L; Zecca L; Smirne S
Arch Neurol; 1982 Nov; 39(11):709-12. PubMed ID: 6181768
[TBL] [Abstract][Full Text] [Related]
18. CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.
Seeldrayers P; Messina D; Desmedt D; Dalesio O; Hildebrand J
Acta Neurol Scand; 1985 May; 71(5):411-4. PubMed ID: 2409733
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Lepola U; Jolkkonen J; Rimón R; Riekkinen P
Neuropsychobiology; 1989; 21(4):182-6. PubMed ID: 2483580
[TBL] [Abstract][Full Text] [Related]
20. CSF creatinine in schizophrenia.
Swahn CG; Sedvall G
Biol Psychiatry; 1988 Mar; 23(6):586-94. PubMed ID: 2451543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
